Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference

    NEXT STORY
    SIGA Announces Canadian Department of National Defence Intent to Purchase Up To 15,325 Courses of Oral TPOXX®
    PREV STORY
    Generex Biotechnology Announces Funding Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ABLYNX PRICES $200 MILLION INITIAL PUBLIC OFFERING IN THE UNITED STATES

    REGULATED INFORMATION - INSIDE INFORMATION25 October 2017 - 2 am CEST GHENT, Belgium, 25 ...

    author_avatar
    NASDAQ Market News

    Atara Biotherapeutics Announces Presentations Highlighting Robust Off-the-Shelf, Allogeneic T-Cell Immunotherapy Pipeline and Next-Generation CAR T Technologies at the 60th American Society of Hematology (ASH) Annual Meeting and European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2018

    Moffitt Cancer Center collaborators to present next-generation chimeric antigen receptor T-cell (CAR T) technology ...

    author_avatar
    NASDAQ Market News

    Research Supporting Favorable Findings on K2M’s RAVINE® Lateral Access System to Be Presented at SpineWeek 2016

    LEESBURG, Va., May 16, 2016 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the ...

    author_avatar
    NASDAQ Market News